Letter: Natural dangers outside the laboratory

Dr Tom Blanchard
Friday 04 February 1994 19:02 EST
Comments

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

Sir: While I would be the first to agree that regulation of genetic engineering is essential, especially where oncogenes inserted in adenoviruses are concerned, a lethal new pathogen is much more likely to evolve in nature than in well-run laboratories ('Scientists must halt killer virus project', 4 February).

Infectious disease is rife for most of the world's population, showing close correlation with poverty, poor sanitation, poor education, high fertility, poor access to basic health care and hot climates. There is ample evidence of rapid genetic change of existing lethal pathogens, eg new strains of drug-resistant tuberculosis, new influenza variants. HIV has apparently evolved only in the latter half of this century, with the current epidemic centred on sub-Saharan Africa, and continues to change rapidly.

To contain nature's genetic experimentation must be the main objective. This requires attention to the basic requirements of public health and the development of new vaccines which must be effective, cheap and available for use in the parts of the world where they are needed most. Vaccine development is critically dependent on the safe application of recent advances in genetic engineering.

Yours faithfully,

TOM BLANCHARD

Research Fellow

London School of Hygiene and Tropical Medicine

London, WC1

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in